CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market sale CFO and CBO sold 2,032 shares at $8.53 ($17,335)
- 4 Open-market sale President and Chief Executive sold 1,436 shares at $8.54 ($12,265)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 5,000 shares at $7.73 ($38,660)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale President and Chief Executive sold 5,821 shares at $8.20 ($47,729)
- 4 Grant or award Chief Operating Officer acquired 45,000 shares (grant or award)
- 4 Grant or award CFO and CBO acquired 33,000 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $7.00 ($35,000)
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale CFO and CBO sold 2,159 shares at $9.60 ($20,726)
- 4 Open-market sale President and Chief Executive sold 1,526 shares at $9.60 ($14,650)
Page 13 of 25 · 496 filings